The follow-up vaccine CV9104 encodes six antigens, i.e., PSA, PSMA, PSCA, STEAP, mucin 1, and prostatic acid phosphatase (PAP), which are overexpressed in prostate cancer cells compared to those in healthy tissues [98]. This evidence concerns the gene KLK3 and prostate carcinoma.